Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 5 studies | 26% ± 10% | |
epithelial cell | 5 studies | 30% ± 10% | |
astrocyte | 3 studies | 20% ± 4% |
Insufficient scRNA-seq data for expression of ERLIN2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2357.41 | 1445 / 1445 | 100% | 31.38 | 183 / 183 |
pancreas | 100% | 2804.59 | 328 / 328 | 100% | 24.55 | 178 / 178 |
lung | 100% | 2257.08 | 578 / 578 | 100% | 36.13 | 1153 / 1155 |
breast | 100% | 3152.02 | 459 / 459 | 100% | 58.60 | 1115 / 1118 |
prostate | 100% | 2826.49 | 245 / 245 | 100% | 43.28 | 500 / 502 |
brain | 100% | 2133.56 | 2638 / 2642 | 100% | 36.71 | 703 / 705 |
thymus | 100% | 4231.31 | 653 / 653 | 99% | 41.85 | 601 / 605 |
stomach | 100% | 2652.08 | 359 / 359 | 99% | 27.41 | 284 / 286 |
kidney | 100% | 2968.65 | 89 / 89 | 99% | 34.56 | 894 / 901 |
intestine | 100% | 2851.47 | 966 / 966 | 99% | 28.06 | 521 / 527 |
bladder | 100% | 3581.62 | 21 / 21 | 98% | 31.13 | 495 / 504 |
uterus | 100% | 3150.09 | 170 / 170 | 98% | 23.26 | 448 / 459 |
ovary | 100% | 3711.99 | 180 / 180 | 97% | 20.25 | 418 / 430 |
skin | 100% | 3675.93 | 1809 / 1809 | 95% | 25.40 | 450 / 472 |
adrenal gland | 100% | 2847.88 | 258 / 258 | 93% | 15.51 | 213 / 230 |
liver | 100% | 2626.83 | 226 / 226 | 90% | 17.18 | 367 / 406 |
adipose | 100% | 2778.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3157.70 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1905.13 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.60 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.20 | 1 / 1 |
muscle | 100% | 1583.35 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 1584.92 | 822 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 16.84 | 74 / 80 |
lymph node | 0% | 0 | 0 / 0 | 76% | 8.41 | 22 / 29 |
peripheral blood | 75% | 1418.27 | 697 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0032933 | Biological process | SREBP signaling pathway |
GO_0045540 | Biological process | regulation of cholesterol biosynthetic process |
GO_0036503 | Biological process | ERAD pathway |
GO_0045717 | Biological process | negative regulation of fatty acid biosynthetic process |
GO_0045541 | Biological process | negative regulation of cholesterol biosynthetic process |
GO_0045121 | Cellular component | membrane raft |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0015485 | Molecular function | cholesterol binding |
GO_0005515 | Molecular function | protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
Gene name | ERLIN2 |
Protein name | Erlin (SPFH domain-containing protein) (Endoplasmic reticulum lipid raft-associated protein) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein) Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2) (SPFH domain-containing protein 2) |
Synonyms | C8orf2 SPFH2 UNQ2441/PRO5003/PRO9924 |
Description | FUNCTION: Component of the ERLIN1/ERLIN2 complex which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs) such as ITPR1 . Promotes sterol-accelerated ERAD of HMGCR probably implicating an AMFR/gp78-containing ubiquitin ligase complex . Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. May promote ER retention of the SCAP-SREBF complex . . FUNCTION: Mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. . FUNCTION: Mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. . |
Accessions | ENST00000648919.1 [O94905-2] E5RJ09 ENST00000523107.5 [O94905-3] ENST00000521644.5 E5RHW4 ENST00000519638.3 [O94905-1] ENST00000335171.10 [O94905-2] ENST00000518586.5 [O94905-3] O94905 ENST00000523887.5 [O94905-3] ENST00000518526.5 |